
Hung Nguyen
Examiner (ID: 4124, Phone: (571)272-2124 , Office: P/2882 )
| Most Active Art Unit | 2882 |
| Art Unit(s) | 2851, 2882 |
| Total Applications | 3002 |
| Issued Applications | 2623 |
| Pending Applications | 119 |
| Abandoned Applications | 304 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18895509
[patent_doc_number] => 20240010994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => PRODUCTION OF LYTIC PHAGES
[patent_app_type] => utility
[patent_app_number] => 18/348910
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18348910
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/348910 | Production of lytic phages | Jul 6, 2023 | Issued |
Array
(
[id] => 19060388
[patent_doc_number] => 11939598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Production bacterial cells and use thereof in production methods
[patent_app_type] => utility
[patent_app_number] => 18/319918
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 35399
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319918 | Production bacterial cells and use thereof in production methods | May 17, 2023 | Issued |
Array
(
[id] => 18724382
[patent_doc_number] => 20230338527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/979309
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/979309 | Liquid pharmaceutical composition | Nov 1, 2022 | Issued |
Array
(
[id] => 18619187
[patent_doc_number] => 11752209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Liquid pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 17/979272
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 26910
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/979272 | Liquid pharmaceutical composition | Nov 1, 2022 | Issued |
Array
(
[id] => 18315316
[patent_doc_number] => 11629387
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-04-18
[patent_title] => Methods and devices for COVID-19 testing using urine samples
[patent_app_type] => utility
[patent_app_number] => 17/845031
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 15274
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845031 | Methods and devices for COVID-19 testing using urine samples | Jun 20, 2022 | Issued |
Array
(
[id] => 19737214
[patent_doc_number] => 12214022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Sequence-specific antimicrobials by blocking DNA repair
[patent_app_type] => utility
[patent_app_number] => 17/831507
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 13793
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831507 | Sequence-specific antimicrobials by blocking DNA repair | Jun 2, 2022 | Issued |
Array
(
[id] => 18590420
[patent_doc_number] => 11739304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Production of lytic phages
[patent_app_type] => utility
[patent_app_number] => 17/742693
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 32886
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742693
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742693 | Production of lytic phages | May 11, 2022 | Issued |
Array
(
[id] => 18492391
[patent_doc_number] => 11697802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Production bacterial cells and use thereof in production methods
[patent_app_type] => utility
[patent_app_number] => 17/742671
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 35355
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742671 | Production bacterial cells and use thereof in production methods | May 11, 2022 | Issued |
Array
(
[id] => 17577026
[patent_doc_number] => 20220133881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => HERPESVIRUS COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/576021
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576021 | Herpesvirus compositions and related methods | Jan 13, 2022 | Issued |
Array
(
[id] => 19717336
[patent_doc_number] => 12202859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Hepatitis c virus E1/E2 heterodimers and methods of producing same
[patent_app_type] => utility
[patent_app_number] => 17/509808
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 30
[patent_no_of_words] => 38505
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17509808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/509808 | Hepatitis c virus E1/E2 heterodimers and methods of producing same | Oct 24, 2021 | Issued |
Array
(
[id] => 17336351
[patent_doc_number] => 20220002682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ALPHAVIRUS REPLICON PARTICLE
[patent_app_type] => utility
[patent_app_number] => 17/481495
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481495 | Alphavirus replicon particle | Sep 21, 2021 | Issued |
Array
(
[id] => 17343669
[patent_doc_number] => 20220010000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
[patent_app_type] => utility
[patent_app_number] => 17/480984
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480984 | IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS | Sep 20, 2021 | Abandoned |
Array
(
[id] => 17228997
[patent_doc_number] => 20210355553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => KITS FOR DETECTING HEV NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/381511
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/381511 | KITS FOR DETECTING HEV NUCLEIC ACID | Jul 20, 2021 | Abandoned |
Array
(
[id] => 19076705
[patent_doc_number] => 11946056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Optimized vector for delivery in microbial populations
[patent_app_type] => utility
[patent_app_number] => 17/356079
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 29694
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356079 | Optimized vector for delivery in microbial populations | Jun 22, 2021 | Issued |
Array
(
[id] => 17168881
[patent_doc_number] => 20210322551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/348368
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348368 | LIQUID PHARMACEUTICAL COMPOSITION | Jun 14, 2021 | Abandoned |
Array
(
[id] => 17140251
[patent_doc_number] => 20210308262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/348078
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348078 | LIQUID PHARMACEUTICAL COMPOSITION | Jun 14, 2021 | Abandoned |
Array
(
[id] => 17292527
[patent_doc_number] => 20210388366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => PLANT-PRODUCED CHIMAERIC ORBIVIRUS VLPS
[patent_app_type] => utility
[patent_app_number] => 17/335404
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335404
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335404 | Plant-produced chimaeric orbivirus VLPs | May 31, 2021 | Issued |
Array
(
[id] => 19013267
[patent_doc_number] => 11920185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Method of inactivating microbes by citraconic anhydride
[patent_app_type] => utility
[patent_app_number] => 17/233744
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 11839
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233744 | Method of inactivating microbes by citraconic anhydride | Apr 18, 2021 | Issued |
Array
(
[id] => 16930935
[patent_doc_number] => 20210196824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/198983
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198983 | Liquid pharmaceutical composition | Mar 10, 2021 | Issued |
Array
(
[id] => 17007398
[patent_doc_number] => 20210238559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => Methods and Systems for Rapid Detection of Microorganisms Using Infectious Agents
[patent_app_type] => utility
[patent_app_number] => 17/170357
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170357 | Methods and Systems for Rapid Detection of Microorganisms Using Infectious Agents | Feb 7, 2021 | Abandoned |